Baudry, G.; Pozzi, M.; Aubry, M.; Hugon-Vallet, E.; Mocan, R.; Chalabreysse, L.; Portran, P.; Obadia, J.-F.; Thaunat, O.; Girerd, N.;
et al. De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival. J. Clin. Med. 2022, 11, 3731.
https://doi.org/10.3390/jcm11133731
AMA Style
Baudry G, Pozzi M, Aubry M, Hugon-Vallet E, Mocan R, Chalabreysse L, Portran P, Obadia J-F, Thaunat O, Girerd N,
et al. De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival. Journal of Clinical Medicine. 2022; 11(13):3731.
https://doi.org/10.3390/jcm11133731
Chicago/Turabian Style
Baudry, Guillaume, Matteo Pozzi, Matthieu Aubry, Elisabeth Hugon-Vallet, Raluca Mocan, Lara Chalabreysse, Philippe Portran, Jean-François Obadia, Olivier Thaunat, Nicolas Girerd,
and et al. 2022. "De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival" Journal of Clinical Medicine 11, no. 13: 3731.
https://doi.org/10.3390/jcm11133731
APA Style
Baudry, G., Pozzi, M., Aubry, M., Hugon-Vallet, E., Mocan, R., Chalabreysse, L., Portran, P., Obadia, J.-F., Thaunat, O., Girerd, N., Dubois, V., & Sebbag, L.
(2022). De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival. Journal of Clinical Medicine, 11(13), 3731.
https://doi.org/10.3390/jcm11133731
